Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | NASDAQ | USD
Last | 3:23 PM EST
5.49quote price arrow up+0.02 (+0.42%)
Volume
554,623
52 week range
2.50 - 9.49
Loading...
  • Open5.48
  • Day High5.57
  • Day Low5.36
  • Prev Close5.47
  • 52 Week High9.49
  • 52 Week High Date11/01/22
  • 52 Week Low2.50
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap684.40M
  • Shares Out124.59M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-1.79

KEY STATS

  • Open5.48
  • Day High5.57
  • Day Low5.36
  • Prev Close5.47
  • 52 Week High9.49
  • 52 Week High Date11/01/22
  • 52 Week Low2.50
  • 52 Week Low Date06/16/22
  • Market Cap684.40M
  • Shares Out124.59M
  • 10 Day Average Volume0.65M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-1.79

RATIOS/PROFITABILITY

  • EPS (TTM)-2.35
  • P/E (TTM)-2.34
  • Fwd P/E (NTM)-4.88
  • EBITDA (TTM)-221.061M
  • ROE (TTM)-190.17%
  • Revenue (TTM)13.37M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,729.94%
  • Debt To Equity (MRQ)75.25%

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

 

Profile

MORE
Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The Company's lead product candidate, SER-109, is designed to reduce further recurrences of Clostridioides difficle infection (CDI). It is also developing therapeutics, such as...
Stephen Berenson
Independent Chairman of the Board
Eric Shaff
President, Chief Executive Officer, Director
David Arkowitz
Chief Financial Officer, Executive Vice President, Head of Business Development
David Ege Ph.D.
Executive Vice President, Chief Technology Officer
Matthew Henn Ph.D.
Executive Vice President, Chief Scientific Officer
Address
200 Sidney St
Cambridge, MA
02139-4218
United States

Top Peers

SYMBOLLASTCHG%CHG
FULC
Fulcrum Therapeutics Inc
12.81+0.20+1.59%
MRSN
Mersana Therapeutics Inc
6.66+0.08+1.22%
ANAB
AnaptysBio Inc
24.95+0.06+0.22%
FDMT
4D Molecular Therapeutics Inc
21.74+0.69+3.28%
EWTX
Edgewise Therapeutics Inc
10.32+0.09+0.88%